Malte Kroenig
Papers
1
Total Citations
30
H-Index
1
About
Malte Kroenig is a leading figure in urological oncology, with a focused expertise in advancing the diagnostic accuracy of prostate cancer detection. His primary research centers on the integration of robotic guidance and software-based imaging to refine transperineal prostate biopsy techniques. Kroenig’s major contribution is the validation of MRI/TRUS fusion biopsy as a superior method for identifying clinically significant prostate cancer, particularly in high-risk patients with prior negative biopsies. His landmark 2016 study, which has garnered over 30 citations, demonstrated that a robot-guided, software-based transperineal approach significantly improves cancer detection rates compared to systematic biopsies alone. This work addresses a critical clinical challenge—reducing false negatives in men with persistently elevated PSA levels. By combining targeted and volume-adapted systematic sampling, Kroenig’s protocol enhances diagnostic precision while minimizing procedural morbidity. His research has been instrumental in shifting clinical practice toward more accurate, minimally invasive diagnostic pathways, directly impacting patient management and treatment planning. Kroenig’s contributions underscore the transformative potential of precision medicine in urology, offering a robust framework for future innovations in image-guided biopsy.
Research Focus
Key Achievements
Top Papers
- 1